Your browser doesn't support javascript.
loading
Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the EORTC/GIMEMA AML-14A trial.
Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J M; Venditti, Adriano; Ramadan, Safaa M; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, Sébastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, Frédéric.
Afiliação
  • Selleslag D; Department of Hematology AZ St-Jan Brugge-Oostende, Belgium.
  • Suciu S; EORTC Headquarters, Brussels, Belgium.
  • Meloni G; Hematology, Sapienza University, Rome, Italy.
  • Muus P; Department of Hematology, Radboud University, Medical Center, Nijmegen, the Netherlands.
  • Halkes CJ; Department of Hematology, Leiden University Medical Center, the Netherlands.
  • Venditti A; Department of Hematology and of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Ramadan SM; EORTC Headquarters, Brussels, Belgium.
  • Pruijt H; Department of Hematology, Istituto Europeo di Oncologia, Milan, Italy.
  • Meert L; Jeroen Bosch Medical Center, Den Bosch, the Netherlands.
  • Vignetti M; EORTC Headquarters, Brussels, Belgium.
  • Marie JP; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA), Rome, Italy.
  • Wittnebel S; Department of Hematology, Hôpital Saint-Antoine, APHP, Paris, France.
  • de Witte T; Department of Hematology, Institut Jules Bordet, ULB, Brussels, Belgium.
  • Amadori S; Department of Tumorimmunology, Radboud University, Medical Center, Nijmegen, the Netherlands.
  • Willemze R; Department of Hematology and of Biomedicine and Prevention, Tor Vergata University, Rome, Italy.
  • Baron F; Department of Hematology, Leiden University Medical Center, the Netherlands.
Haematologica ; 102(2): e47-e51, 2017 02.
Article em En | MEDLINE | ID: mdl-27789677

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Arabinonucleosídeos / Nucleotídeos de Adenina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Transplante de Células-Tronco Hematopoéticas / Citarabina Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Arabinonucleosídeos / Nucleotídeos de Adenina / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Transplante de Células-Tronco Hematopoéticas / Citarabina Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Ano de publicação: 2017 Tipo de documento: Article